Perfluoro-n-nonanoic acid


Curated chemical-disease associations from CTD
Disease IDDisease nameReference
MESH:D001249 Asthma PMID:31730470
MESH:D001724 Birth Weight PMID:36920051
MESH:D001943 Breast Neoplasms PMID:32580117
MESH:D002779 Cholestasis PMID:29112762
MESH:D006528 Carcinoma, Hepatocellular PMID:21984479
MESH:D006529 Hepatomegaly PMID:22648072; PMID:25543169; PMID:28049043; PMID:28558994
MESH:D006932 Hyperbilirubinemia PMID:29112762
MESH:D006973 Hypertension PMID:32958007
MESH:D008114 Liver Neoplasms, Experimental PMID:21984479
MESH:D008545 Melanoma PMID:37718377
MESH:D010024 Osteoporosis PMID:26058082
MESH:D011297 Prenatal Exposure Delayed Effects PMID:25543169; PMID:34500360; PMID:34585601
MESH:D011628 Puberty, Delayed PMID:25543169
MESH:D014594 Uterine Neoplasms PMID:37718377
MESH:D015431 Weight Loss PMID:19196829
MESH:D018248 Adenoma, Liver Cell PMID:21984479
MESH:D056486 Chemical and Drug Induced Liver Injury PMID:22387981
MESH:D065626 Non-alcoholic Fatty Liver Disease PMID:28049043
MESH:D066087 Perinatal Death PMID:25543169
OMIM:613207 ASTHMA-RELATED TRAITS, SUSCEPTIBILITY TO, 8 PMID:32717646

DISCLAIMER

We have built a comprehensive resource which compiles potential endocrine disrupting chemicals (EDCs) based on the observed adverse effects or endocrine-mediated endpoints in published experiments on humans or rodents to support basic research. We are not responsible for any errors or omissions in the published research articles or supporting literature on potential EDCs compiled in this resource. Users are advised to exercise their own judgement on the weight of evidence for potential EDCs compiled in this resource. Importantly, our sole goal to build this resource on potential EDCs is to enable future basic research towards better understanding of the systems-level perturbations upon chemical exposure rather than influencing regulatory advice on chemical use.